化合物5-Hydroxydecanoate sodium T29457L
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
200 mg | 71186-53-3 | ¥1,730.00 | 询底价 |
10 mg | 71186-53-3 | ¥277.00 | 询底价 |
50 mg | 71186-53-3 | ¥795.00 | 询底价 |
100 mg | 71186-53-3 | ¥1,160.00 | 询底价 |
1 mL | 71186-53-3 | ¥448.00 | 询底价 |
25 mg | 71186-53-3 | ¥495.00 | 询底价 |
Product Introduction
Bioactivity
英文名: 5-Hydroxydecanoate sodium
描述: 5-Hydroxydecanoate sodium 是一种选择性 ATP 敏感的 K+ (KATP) 通道阻滞剂,IC50 约为 30 μM。 它是线粒体外膜酰基辅酶A 合成酶的底物,具有抗氧化性。
体外活性: The treatment of 5-Hydroxydecanoate sodium abolished the beneficial effects of penehyclidine hydrochloride (PHC) preconditioning in anoxia/reoxygenation (A/R)‐induced injury in H9c2 cells. 5-Hydroxydecanoate sodium blocked the inhibitory effect of PHC on Ca2+ overload and ROS production and promoted the release of Cyt-C from mitochondria into cytoplasm. 5-Hydroxydecanoate sodium attenuated the anti-apoptotic effect of PHC[1].
体内活性: The treatment of 5-Hydroxydecanoate sodium (100 μM) abolished the effects of ischemic preconditioning (IPC) on the contractile recovery, but 5-Hydroxydecanoate sodium did not affect its effect on the contracture, lactate production, glycogenolysis and viable tissue in rats[2].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 3.6 mg/mL (17.12 mM)
关键字: 5 Hydroxydecanoate sodium | 5Hydroxydecanoate sodium | 5-Hydroxydecanoate sodium
相关产品: Vernakalant Hydrochloride | Rosuvastatin calcium | Cesium chloride | AVE-0118 | Tolbutamide | Tipepidine hydrochloride | N-Acetylprocainamide | DPO-1 | Dihydroisotanshinone I | Branaplam
化合物5-Hydroxydecanoate sodium T29457L信息由TargetMol中国为您提供,如您想了解更多关于化合物5-Hydroxydecanoate sodium T29457L报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途